A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 354 participants.

Also called NCT06455098

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 354 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06455098
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06455098. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06-28 (actual); primary completion 2027-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
Acronym
OMNY-AF
Intervention (Device)
OMNYPULSE™ Catheter with the TRUPULSE Generator
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06455098
Content hash
1a6749bcf3d2c452b72cb071442bf38d09b3d9c24e71516a26dfeb770c09ac67